This study estimates the research antibodies market size (including reagents) for 2017 and projects its demand till 2022. Top-down and bottom-up approaches were used to validate the size of this market and estimate the size of other dependent submarkets.
“The global research antibodies market (including reagents) is projected to grow at a CAGR of 6.2%.”
The research antibodies market (including reagents) is estimated to grow at a CAGR of 6.2% from 2017 to 2022, to reach USD 12.60 billion by 2022 from USD 9.33 billion in 2017. The increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research & drug discovery, and growing collaboration between industries and academic institutes are the major factors responsible for the growth of the market during the forecast period.
However, the quality concerns over research antibodies (with respect to research reproducibility), cost- and time- intensive antibody development processes, and the pricing pressures faced by prominent market players are the major challenges currently at play in the market.
“The antibodies segment is expected to grow at the fastest rate during the forecast period.”
By product, the research antibodies market (including reagents)is segmented into antibodies and reagents.
The research antibodies segment is expected to register the highest CAGR during the forecast period owing to their high sensitivity, specificity, and affinity in various research reactions. they are majorly used in proteomic research and drug development for identification, regulatory characterization, and discovery.
- Pharmaceutical and Biotechnology Companies
- Life Sciences Companies
- Academic Research Institutes
- Government Institutes
- Private Research Firms
- Contract Research Organizations (CROs)
- Venture Capitalists and Investors
Scope of the research :
The research report categorizes the research antibodies and reagents market into the following segments and subsegments:
Global Research Antibodies Market, by Product
- Antibodies Market, by Type
- o Primary Antibodies
- o Secondary Antibodies
- Antibodies Market, by Source
- o Mouse
- o Rabbit
- o Others
12 Company Profiles
(Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy)*
12.1 Thermo Fisher Scientific Inc.
12.2 Merck Group
12.3 Abcam PLC
12.4 Becton, Dickinson and Company
12.5 Cell Signaling Technology, Inc.
12.6 Bio-Rad Laboratories, Inc.
12.7 F. Hoffmann-La Roche Ltd
12.8 Agilent Technologies, Inc.
12.9 Danaher Corporation
12.12 Perkinelmer, Inc.
12.13 Biolegend, Inc.
*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy Might Not Be Captured in Case of Unlisted Companies.